Manpreet Kaur Saini

Employment

• International Centre for Genetic Engineering and Biotechnology Research Associate
  2024 - Present
• Emory University Postdoc Fellow
  2022 - 2024
• Emory University Exchange Graduate Student
  2020 - 2023
• International Center for Genetic Engineering and Biotechnology Graduate Student
  2016 - 2023

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• Shared germline-biased plasmablast clonotypes shape early neutralizing antibody responses during acute Chikungunya virus infection
  Frontiers in Immunology 2026 DOI: 10.3389/fimmu.2026.1846926
  +Save
• Optimizing Tissue Harvesting Techniques for Establishing Patient-Derived Glioblastoma Organoids
  World Neurosurgery 2024 DOI: 10.1016/j.wneu.2024.07.026
  +Save
• Severe disease during both primary and secondary dengue virus infections in pediatric populations
  Nature Medicine 2024
  +Save
• Comparison of Resection Assisting Devices in the Process of Collecting Brain Tumor Tissue for Basic Research: Microdebrider Versus Ultrasonic Aspirator
  World Neurosurgery 2024 DOI: 10.1016/j.wneu.2023.10.066
  +Save
• Supplementary Figure SF4 from Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
  2023 DOI: 10.1158/2767-9764.22546029
  +Save
• Supplementary Table ST3 from Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
  2023 DOI: 10.1158/2767-9764.22546017
  +Save
• Supplementary Table ST3 from Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
  2023 DOI: 10.1158/2767-9764.22546017.v1
  +Save
• Supplementary Table ST2 from Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
  2023 DOI: 10.1158/2767-9764.22546020
  +Save
• Supplementary Table ST2 from Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
  2023 DOI: 10.1158/2767-9764.22546020.v1
  +Save
• Supplementary Table ST1 from Antibody Binding and Neutralization of Live SARS-CoV-2 Variants Including BA.4/5 Following Booster Vaccination of Patients with B-cell Malignancies
  2023 DOI: 10.1158/2767-9764.22546023
  +Save